ivWatch Crisscrossing Globe in May and June to Attend Key Vascular Access, Nursing and MedTech Conferences

Company to showcase patented IV safety technology as global adoption continues

NEWPORT NEWS, Va. — May 7, 2024 ivWatch, LLC, the IV safety company, today unveiled its schedule of conference exhibitions and speaking engagements for May and June, including the Emirates Critical Care Conference (ECCC) in Dubai; the National Teaching Institute & Critical Care Exposition (NTI) in Denver; the National Institute and Vascular Access Society (NIVAS) Conference in Manchester, England; and the National Infusion Center Annual Conference (NICA2024) in Las Vegas.

Details of these upcoming conferences include:

Emirates Critical Care Conference (ECCC)

Intercontinental Hotel, Event Centre Booth 23, Dubai Festival City, UAE, May 10-12, 2024 

Joining MEDWING in its booth at the conference, ivWatch experts will educate attendees on the importance of extravasation detection and improving patient safety for nurse practitioners and their patients. Continuous IV site monitoring technology will be prominently displayed, and ivWatch experts will be on-site to discuss the dangers of IV extravasations and the importance of IV injury prevention.

National Teaching Institute & Critical Care Exposition (NTI)

Colorado Convention Center Booth 2019, Denver, May 20-22, 2024

Showcasing its “Pain Should Not Be Silenced” gallery exhibition paying tribute to patients who have suffered IV extravasation injuries, ivWatch experts will educate attendees on the hidden causes of infiltration and extravasation, and the importance of early detection and improving patient safety for clinicians and their patients. The company’s continuous IV site monitoring technology will be on display, and the ivWatch team will be on-site to demonstrate and discuss its role in reducing infiltrations and extravasations injuries.

National Institute and Vascular Access Society (NIVAS) Conference 2024

Hilton Manchester Deansgate Hotel, Manchester, England, June 6-7, 2024

Exhibiting for the second year in a row, ivWatch’s IV monitoring technology will be featured in the booth, with product experts and clinicians providing live product demonstrations.

Pain is Not an Option: Changing How to Monitor IVs for Extravasations  – June 7, 9:05 – 9:30 a.m., 

NIVAS Chair Andrew Barton, national lead for extravasation and nurse consultant in vascular access and IV therapy at Frimley Health NHS Foundation Trust, will discuss the new NIVAS UK Extravasation Toolkit he and his team developed as a modern advancement to improving patient safety and care for IVs. He will show how hospitals can use this model to develop their own extravasation toolkits. Barton will also share the results of a study completed at Frimley Health NHS Foundation using ivWatch technology and discuss how integrating it has prevented scores of potentially serious vesicant and non-vesicant extravasation injuries they regularly saw prior to continuous monitoring technology.

National Infusion Center Annual Conference (NICA2024)

MGM Grand Exhibit Hall Booth 207, Las Vegas, June 21-22, 2024 

A NICA partner, ivWatch will showcase its continuous IV site monitoring technology, and company experts will meet with infusion center owners, managers and clinicians to educate them on the hidden dangers of infiltration and extravasation, the inherent risk this clinical gap poses to their organizations, and the importance of early detection and improving patient safety. ivWatch will also be a key participant at the exclusive NICA Infusion Center of Excellence (NICE) Experience, which provides an insider look at the ideal infusion center model. The event will provide a firsthand immersive experience for clinicians, administrators, managers, and owners.

To learn more about the ivWatch patient monitoring system for IV infiltrations and extravasations visit: https://www.ivwatch.com/tech-overview/.

 

About ivWatch, LLC
Founded in 2010 and holding nearly 70 patents, ivWatch developed a first-of-its-kind Class II medical device, cleared by the FDA and CE-marked, that uses visible and near-infrared light and a predictive algorithm to continuously monitor peripheral IVs and aid in the early detection of IV infiltration and extravasation events. These events are common and can lead to severe consequences ranging from dosing errors, scarring, skin staining, nerve damage, amputation, and even death.

The ivWatch patient monitoring system performs over 18,000 checks per hour for signs of IV infiltration and extravasation, notifying healthcare workers of fluid leaking outside of the vein in real time to reduce severe adverse outcomes.

In 2023, the company surpassed more than 30 clinical bodies of evidence. It was named to Fast Company’s Most Innovative Companies 2024 list and was also awarded a PM360 Innovative Health Award in the Health-Tech/Non-Consumer category and named a Fierce Life Sciences Innovation Award finalist for medical device innovation, both in 2023. To learn more, www.ivWatch.com.